Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cormorant Asset Management
Boston, Massachusetts, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cormorant Asset Management is a Boston-based investment management firm founded in 2013. It focuses on early-stage and innovative companies in the biotechnology and life sciences sectors across both public and private markets. The firm manages multiple funds targeting healthcare investments globally and has been recognized as one of the most active private biopharma investors in recent years.
- Industry
- Investors
Beyond the preview
Go deeper on Cormorant Asset Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cormorant Asset Management.